ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,353.18
0.03%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX

  6. HLS Therapeutics Inc (HLS) Share Price

HLS HLS Therapeutics Inc

3.65
0.10 (2.82%)
07 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 HLS Therapeutics Inc TSX:HLS Toronto Stock Exchange Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.10 2.82 3.65 3.52 3.77 3.70 3.65 3.7 700 20:10:13   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 63.61M -27.53M -0.8609 -4.24 116.73M
 Type  Size  Price  Time  Units 
  100 3.65 17:28:02 CAD
 
Recent News
DateTimeSource
HeadlineMore HLS News
08/06/202400:00PRNCAHLS Therapeutics Reports Annual Meeting Results
28/05/202411:30PRNCANew Study Published on the Impact of Pharmaceutical Support Programs on Persistence with Clozapine Treatment
28/05/202411:30PRNCAPublication d'une nouvelle étude sur l'impact des programmes de soutien aux patients sur la persistance au traitement à la clozapine
09/05/202411:30PRNCAHLS Therapeutics Announces Q1 2024 Financial Results
25/04/202413:50PRNCAHLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call
09/04/202411:30PRNCAHLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
08/04/202411:30PRNCANew REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
18/04/202112:44PBBHELESI Plc, Growth On The Back Of Legislation.189
22/09/200507:18PBBwhat's with the comedy bid / offer 2-6p?nm3
15/01/200309:47PBBHLS - MONEY BACK TIME1
Data Downloads for HLS

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest HLS Therapeutics Inc Articles